Javascript must be enabled to continue!
Delay to initiate treatment is associated with unsuccessful treatment outcome among new pulmonary tuberculosis patients in Tigray, Northern Ethiopia: a follow up study
View through CrossRef
Abstract
Background : Previous studies in Ethiopia indicated that tuberculosis (TB) patient’s elapse long time before treatment initiation. However, there is very limited evidence on the association of delay to initiate treatment with treatment outcome.
Objective : To investigate the association of time to treatment initiation delay with treatment outcomes of new adult TB patients in Tigray region of Ethiopia.
Methods : We conducted a follow up study from October 2018 to April 2020 by recruiting 875 newly diagnosed Pulmonary Tuberculosis (PTB) patients from 21 randomly selected health facilities. Study participants were selected using simple random sampling technique during treatment initiation from October 1/2018 to October 30/2019. Delay to initiate treatment and treatment outcome were collected using standardized questionnaire and laboratory investigation. Adherence of TB patients to their treatment was collected using a 10 points linear visual analogue scale (VAS) at the end of treatment. The association of delay to initiate treatment with treatment outcome was modeled using log binomial regression model. Statistical significance was reported whenever p-value was less than 0.05. Data was analyzed using SPSS software version 21.
Result : The median total delay to treatment initiation was 62 days with inter-quartile range of 16-221 days. A unite increase in a day to initiate treatment results in increment of risk of unsuccessful treatment outcome by 2.3. Other factors associated with unsuccessful treatment outcomes were being less adherent to the treatment, HIV co infection, being smear positive at initiation of treatment and after 2 months of treatment initiation.
Conclusion : delay in a day to initiate treatment is associated with increased risk of unsuccessful treatment outcome. Any effort targeted towards reducing the negative effects of PTB should target on strategies that reduces the length of delay to initiate treatment and strengthen community engagement to improve treatment adherence of patients that have started treatment.
Springer Science and Business Media LLC
Title: Delay to initiate treatment is associated with unsuccessful treatment outcome among new pulmonary tuberculosis patients in Tigray, Northern Ethiopia: a follow up study
Description:
Abstract
Background : Previous studies in Ethiopia indicated that tuberculosis (TB) patient’s elapse long time before treatment initiation.
However, there is very limited evidence on the association of delay to initiate treatment with treatment outcome.
Objective : To investigate the association of time to treatment initiation delay with treatment outcomes of new adult TB patients in Tigray region of Ethiopia.
Methods : We conducted a follow up study from October 2018 to April 2020 by recruiting 875 newly diagnosed Pulmonary Tuberculosis (PTB) patients from 21 randomly selected health facilities.
Study participants were selected using simple random sampling technique during treatment initiation from October 1/2018 to October 30/2019.
Delay to initiate treatment and treatment outcome were collected using standardized questionnaire and laboratory investigation.
Adherence of TB patients to their treatment was collected using a 10 points linear visual analogue scale (VAS) at the end of treatment.
The association of delay to initiate treatment with treatment outcome was modeled using log binomial regression model.
Statistical significance was reported whenever p-value was less than 0.
05.
Data was analyzed using SPSS software version 21.
Result : The median total delay to treatment initiation was 62 days with inter-quartile range of 16-221 days.
A unite increase in a day to initiate treatment results in increment of risk of unsuccessful treatment outcome by 2.
3.
Other factors associated with unsuccessful treatment outcomes were being less adherent to the treatment, HIV co infection, being smear positive at initiation of treatment and after 2 months of treatment initiation.
Conclusion : delay in a day to initiate treatment is associated with increased risk of unsuccessful treatment outcome.
Any effort targeted towards reducing the negative effects of PTB should target on strategies that reduces the length of delay to initiate treatment and strengthen community engagement to improve treatment adherence of patients that have started treatment.
Related Results
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea's Claim 20/Ethiopia's Claim 8, Partial Awards. At <http://www.pca-cpa.org>.Eritrea Ethiopia Claims Commission, December 19, 2...
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Abstract
Background :Tuberculosis (TB) is a major public health concern worldwide and is the 13th leading cause of death and the second deadliest infectious disease after C...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract
Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
Peran Unchr dalam Permasalahan Pengungsi Konflik Ethiophia-Tigray
Peran Unchr dalam Permasalahan Pengungsi Konflik Ethiophia-Tigray
The conflict between Ethiopia and Tigray which began in November 2020 is a conflict caused by political and ideological differences between the Federal government of Ethiopia and t...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...

